Executives
?
Brown Jeffrey J
Director
Medifast, Inc.
US, Baltimore [HQ]
CIK
1245377
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
38,316,638
Price per Share :
$15.52
Equivalence :
$594,674,221.76
Transaction History
-
P38,316,638 Shares After TransactionValue : $3,832,813,299.14$62,195,152.95Transaction Date : 08/04/23
-
Footnotes
-
-
Footnotes:#1 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.#2 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.#3 These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.#4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.#5 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
-
P4,136,231 Shares After TransactionValue : $413,747,186.93$6,713,913.57Transaction Date : 08/04/23
-
Footnotes
-
-
Footnotes:#1 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.#2 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.#3 These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.#4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.#5 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
-
P5,725,295 Shares After TransactionValue : $511,955,878.90$3,947,088.22Transaction Date : 08/08/23
-
Footnotes
-
-
Footnotes:#1 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.#2 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.#3 These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.#4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.#5 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
-
S23,162,638 Shares After TransactionValue : $2,144,860,278.80Sold $1,403,260.40Transaction Date : 08/14/23
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.50 to $92.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, and 4 herein.#2 These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.36 to $89.96, inclusive.#4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.93, inclusive.
-
S13,330,638 Shares After TransactionValue : $1,196,957,986.02Sold $882,815.28Transaction Date : 08/15/23
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.50 to $92.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, and 4 herein.#2 These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.36 to $89.96, inclusive.#4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.93, inclusive.